JPRN-jRCT2080223020已完成1 期
A Phase 1b/2 Study of MEDI4736 in Combination With tremelimumab, MEDI4736 Monotherapy, and tremelimumab Monotherapy in Subjects With Metastatic or Recurrent Gastric or Gastroesophageal Junction Adenocarcinoma
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- AstraZeneca
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 ot applicable（—）
- 性别
- All
入选标准
- •1. Male and female subjects
- •2. 18 years and older
- •3. Histological or cytological confirmation of metastatic or recurrent gastric or gastroesophageal junction adenocarcinoma
- •4. Subjects must have received and have progressed, or are refractory to standard regimens
- •5. Subjects must have at least one lesion amenable to biospy
排除标准
- •1. Any concurrent chemotherapy, immunotherapy, biologic, or hormonal therapy for cancer treatment
- •2. Previous immunotherapy
- •3. Concurrent or prior use of immunosuppressive medication with 14 days
- •4. Active or prior documented autoimmune or inflammatory disease within 3 years with some exceptions
研究者
相似试验
已完成
1 期
Phase Ib/II Study of MEDI4736 Evaluated in Different Combinations in Metastatic Pancreatic Ductal CarcinomaMetastatic Pancreatic Ductal AdenocarcinomaNCT02583477AstraZeneca23
已完成
2 期
MEDI4736 Or MEDI4736 + Tremelimumab In Surgically Resectable Malignant Pleural MesotheliomaMesotheliomaNCT02592551Baylor College of Medicine24
已完成
2 期
MEDI4736 and Tremelimumab in Treating Patients With Metastatic HER2 Negative Breast CancerEstrogen Receptor NegativeEstrogen Receptor PositiveHER2/Neu NegativeRecurrent Breast CarcinomaStage IV Breast CancerNCT02536794Northwestern University30
进行中（未招募）
1 期
A study in women with advanced breast cancer treated with standard therapy with or without MEDI-573Advanced Metastatic Breast Cancer (MBC)MedDRA version: 18.1Level: PTClassification code 10057654Term: Breast cancer femaleSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 18.1Level: PTClassification code 10006202Term: Breast cancer stage IVSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 18.1Level: PTClassification code 10055113Term: Breast cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2011-000198-29-DEMedImmune, LLC178
进行中（未招募）
不适用
A study in women with advanced breast cancer treated with standard therapy with or without MEDI-573EUCTR2011-000198-29-GBMedImmune, LLC178